Company / Working Capital
CASTLE BIOSCIENCES INC Working Capital History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$292.4M
FY2025
5-year range
$248.0M / $328.9M
FY2021-FY2025
Trend
-5.9%
vs FY2024
Sector context
#93 of 160
Health Care
What the data says
At $292M, CASTLE BIOSCIENCES INC's working capital ranks #93 of 160 in the Health Care sector. Working Capital has fluctuated over the past 8 years, ranging from $11M in FY2018 to $409M in FY2020.
Based on SEC 10-K filings.
$292M in FY2025 with a 5-year CAGR of -6.5%.
Improved from $248M to $292M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +4.5%
- 5-Year CAGR
- -6.5%
- 10-Year CAGR
- -
Sector benchmark
#93 of 160 in Health CareTop 58% of 160This company $292.4M Sector average $757.1M
▼
-61.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -6.5%, indicating a declining trend.
- In FY2025, working capital decreased 5.9% year-over-year.
- Ranks #93 out of 160 companies in the Health Care sector.
- Peak working capital was recorded in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $292.4M | -5.9% |
| FY2024 | $310.8M | +25.3% |
| FY2023 | $248.0M | -3.2% |
| FY2022 | $256.2M | -22.1% |
| FY2021 | $328.9M | -19.5% |
| FY2020 | $408.7M | +303.1% |
| FY2019 | $101.4M | +790.3% |
| FY2018 | $11.4M | - |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026